Subsidiary, CancerVac, and Canadian based cancer immunotherapy company, Biomira Inc announced a commercial agreement for the development and commercialization of CancerVac's most advanced cancer vaccine product candidate.
Subscribe today for award-winning, unbiased and trusted journalism